Liposomes, lipid-based vesicular systems, have attracted major interest as a means to
improve drug delivery to various organs and tissues in the human body. Recent literature …

For decades, clinicians have used liposomes, self-assembled lipid vesicles, as nanoscale
systems to deliver encapsulated anthracycline molecules for cancer treatment. The more …

The ultimate goal of drug delivery is to increase the bioavailability and reduce the toxic side
effects of the active pharmaceutical ingredient (API) by releasing them at a specific site of …

Vesicles, generally defined as self-assembled structures formed by single or multiple
concentric bilayers that surround an aqueous core, have been widely used for biomedical …

Introduction: Nanoscale assemblies are needed that achieve multiple therapeutic objectives,
including cellular targeting, imaging, diagnostics and drug delivery. These must exhibit high …

Our ability to engineer nanomaterials for biological and medical applications is continuously
increasing, and nanomaterial designs are becoming more and more complex. One very …

Liposomes are artificially-prepared bilayered phospholipid vesicles. Since their discovery,
they have emerged as a promising vehicle for the efficient delivery of active biological …

Specific delivery of therapeutic agents to solid tumors and their bioavailability at the target
site are the most clinically important and challenging goals in cancer therapy. Liposomes …

The focus of drug delivery is shifting toward smart drug carriers that release the cargo in
response to a change in the microenvironment due to an internal or external trigger. As the …

Site-specific delivery of the therapeutic agents to the target site is the most challenging and
most important goal from the clinical point of view. Recently, much effort has been indulged …